Skip to main content
. 2020 Aug;18(4):e418–e442. doi: 10.1016/j.clgc.2019.12.004

Supplemental Table 3.

Summary Statistics Comparison: Missing and Nonmissing Costsa

Variable Missing Values
Nonmissing Values
n Mean n Mean
Year 1
 Age 25 69.16 447 65.75
 BMI 23 27.29 423 27.85
 Gender 25 80% 447 79%
 Never smoked 6 24% 145 32%
 Previous smoker 13 52% 239 53%
 Current smoker 6 24% 63 14%
 ECG result 24 8% 447 22%
 Celecoxib 25 52% 447 50%
 Diabetes 24 13% 442 9%
 History 23 52% 444 33%
Year 2
 Age 30 68.57 442 65.75
 BMI 28 26.91 418 27.88
 Gender 30 80% 442 79%
 Never smoked 7 23% 144 33%
 Previous smoker 19 63% 223 53%
 Current smoker 4 13% 65 15%
 ECG result 29 14% 442 22%
 Celecoxib 30 47% 442 50%
 Diabetes 29 10% 442 9%
 History 28 39% 439 34%
Year 3
 Age 47 68.09 425 65.69
 BMI 45 27.15 401 27.89
 Gender 47 74% 425 80%
 Never smoked 11 23% 140 33%
 Previous smoker 26 55% 226 53%
 Current smoker 10 21% 59 14%
 ECG result 46 11% 425 23%
 Celecoxib 47 43% 425 50%
 Diabetes 46 7% 425 9%
 History 45 42% 422 33%

Abbreviations: BMI = body mass index; ECG = electrocardiography.

a

Patient gender (female = 0; male = 1); ECG result (normal = 1; abnormal = 0); Celecoxib (placebo arm = 0; treatment arm = 1); history (no history of NMIBC = 0; history of NMIBC = 1); diabetes (no diabetes = 0; diabetes = 1).